Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Aug 28, 2026

ALLR — Allarity Therapeutics, Inc. Dilution Risk Tracker

Track ALLR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ALLR — Get alerts when the score changes →

As of August 28, 2026, Allarity Therapeutics, Inc. (ALLR) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. Allarity Therapeutics, Inc. has a market capitalization of $26.09M, 15.91M shares outstanding. Stored dilution-related fields include shelf registration capacity of $6.00M, ATM program capacity of $6.00M, 71.7K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄 Convertible Debt
35

Dilution Forecast

Watch
Minor dilution signals detected
model est. 31%
💰 Capital Raise model 38%
• Active shelf registration ($6M, 23% of market cap)
• Active ATM program with $6M remaining capacity
🔄 Reverse Split model est. 30%
• 50-day avg $1.34 approaching $1 threshold
🔁 Convertible Conversion model 15%
• Convertible debt present: 6.7% potential dilution
🔔 Track ALLR — Get forecast alerts →

Market Data

Market Cap$26.09M
Shares Outstanding15.91M
Float15.74M
Cash$16.98M
Debt$2.94M
Short InterestN/A

Institutional Holdings

5.9% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track ALLR for full holder detail →

Short Interest

Short Interest120.9K
Days to Cover2.1
% of Float0.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-09-30
xbrl XBRL WARRANT 2024-12-31
424B3 ATM 2026-04-27
S-3/A SHELF 2026-04-24
EFFECT EFFECT 2026-04-24
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ALLR Dilution Snapshot

Allarity Therapeutics, Inc. (ALLR) has a DilutionScore of 56/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ALLR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ALLR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ALLR
ALLR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.